Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 2 |
GO:0043226 | organelle | 2 | 2 |
GO:0043227 | membrane-bounded organelle | 3 | 2 |
GO:0043229 | intracellular organelle | 3 | 2 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: Q4QBU3
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 2 |
GO:0003723 | RNA binding | 4 | 2 |
GO:0003729 | mRNA binding | 5 | 2 |
GO:0003755 | peptidyl-prolyl cis-trans isomerase activity | 3 | 10 |
GO:0003824 | catalytic activity | 1 | 10 |
GO:0005488 | binding | 1 | 2 |
GO:0016853 | isomerase activity | 2 | 10 |
GO:0016859 | cis-trans isomerase activity | 3 | 10 |
GO:0097159 | organic cyclic compound binding | 2 | 2 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 10 |
GO:1901363 | heterocyclic compound binding | 2 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 238 | 242 | PF00656 | 0.573 |
CLV_C14_Caspase3-7 | 292 | 296 | PF00656 | 0.638 |
CLV_C14_Caspase3-7 | 345 | 349 | PF00656 | 0.436 |
CLV_NRD_NRD_1 | 148 | 150 | PF00675 | 0.363 |
CLV_NRD_NRD_1 | 362 | 364 | PF00675 | 0.479 |
CLV_NRD_NRD_1 | 419 | 421 | PF00675 | 0.369 |
CLV_PCSK_KEX2_1 | 144 | 146 | PF00082 | 0.384 |
CLV_PCSK_KEX2_1 | 180 | 182 | PF00082 | 0.639 |
CLV_PCSK_KEX2_1 | 362 | 364 | PF00082 | 0.471 |
CLV_PCSK_KEX2_1 | 395 | 397 | PF00082 | 0.375 |
CLV_PCSK_KEX2_1 | 419 | 421 | PF00082 | 0.369 |
CLV_PCSK_PC1ET2_1 | 144 | 146 | PF00082 | 0.371 |
CLV_PCSK_PC1ET2_1 | 180 | 182 | PF00082 | 0.639 |
CLV_PCSK_PC1ET2_1 | 395 | 397 | PF00082 | 0.375 |
CLV_PCSK_PC7_1 | 140 | 146 | PF00082 | 0.365 |
CLV_PCSK_SKI1_1 | 354 | 358 | PF00082 | 0.528 |
DEG_APCC_DBOX_1 | 395 | 403 | PF00400 | 0.469 |
DEG_SPOP_SBC_1 | 233 | 237 | PF00917 | 0.623 |
DEG_SPOP_SBC_1 | 265 | 269 | PF00917 | 0.588 |
DOC_CKS1_1 | 374 | 379 | PF01111 | 0.453 |
DOC_MAPK_gen_1 | 149 | 156 | PF00069 | 0.432 |
DOC_MAPK_gen_1 | 393 | 401 | PF00069 | 0.378 |
DOC_MAPK_MEF2A_6 | 149 | 156 | PF00069 | 0.403 |
DOC_MAPK_MEF2A_6 | 363 | 372 | PF00069 | 0.551 |
DOC_MAPK_MEF2A_6 | 81 | 89 | PF00069 | 0.542 |
DOC_PP4_FxxP_1 | 60 | 63 | PF00568 | 0.410 |
DOC_USP7_MATH_1 | 155 | 159 | PF00917 | 0.371 |
DOC_USP7_MATH_1 | 223 | 227 | PF00917 | 0.556 |
DOC_USP7_MATH_1 | 265 | 269 | PF00917 | 0.739 |
DOC_USP7_MATH_1 | 273 | 277 | PF00917 | 0.678 |
DOC_USP7_MATH_1 | 305 | 309 | PF00917 | 0.734 |
DOC_USP7_MATH_1 | 36 | 40 | PF00917 | 0.575 |
DOC_WW_Pin1_4 | 297 | 302 | PF00397 | 0.673 |
DOC_WW_Pin1_4 | 370 | 375 | PF00397 | 0.532 |
LIG_14-3-3_CanoR_1 | 257 | 262 | PF00244 | 0.685 |
LIG_14-3-3_CanoR_1 | 280 | 284 | PF00244 | 0.571 |
LIG_Actin_WH2_2 | 404 | 421 | PF00022 | 0.469 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.611 |
LIG_BIR_III_4 | 295 | 299 | PF00653 | 0.683 |
LIG_BRCT_BRCA1_1 | 69 | 73 | PF00533 | 0.558 |
LIG_CSL_BTD_1 | 374 | 377 | PF09270 | 0.445 |
LIG_eIF4E_1 | 313 | 319 | PF01652 | 0.551 |
LIG_FHA_1 | 134 | 140 | PF00498 | 0.366 |
LIG_FHA_1 | 166 | 172 | PF00498 | 0.523 |
LIG_FHA_1 | 256 | 262 | PF00498 | 0.649 |
LIG_FHA_1 | 273 | 279 | PF00498 | 0.692 |
LIG_FHA_1 | 46 | 52 | PF00498 | 0.528 |
LIG_FHA_2 | 236 | 242 | PF00498 | 0.663 |
LIG_FHA_2 | 290 | 296 | PF00498 | 0.721 |
LIG_FHA_2 | 374 | 380 | PF00498 | 0.517 |
LIG_FHA_2 | 404 | 410 | PF00498 | 0.341 |
LIG_FHA_2 | 44 | 50 | PF00498 | 0.569 |
LIG_Integrin_RGD_1 | 396 | 398 | PF01839 | 0.469 |
LIG_LIR_Apic_2 | 58 | 63 | PF02991 | 0.410 |
LIG_LIR_Gen_1 | 385 | 392 | PF02991 | 0.402 |
LIG_LIR_Nem_3 | 312 | 316 | PF02991 | 0.535 |
LIG_LIR_Nem_3 | 385 | 390 | PF02991 | 0.359 |
LIG_LYPXL_yS_3 | 84 | 87 | PF13949 | 0.533 |
LIG_SH2_CRK | 313 | 317 | PF00017 | 0.475 |
LIG_SH2_SRC | 313 | 316 | PF00017 | 0.573 |
LIG_SH2_STAP1 | 169 | 173 | PF00017 | 0.526 |
LIG_SH2_STAT5 | 105 | 108 | PF00017 | 0.322 |
LIG_SH2_STAT5 | 355 | 358 | PF00017 | 0.550 |
LIG_SH2_STAT5 | 387 | 390 | PF00017 | 0.440 |
LIG_SH2_STAT5 | 95 | 98 | PF00017 | 0.287 |
LIG_SH3_1 | 145 | 151 | PF00018 | 0.469 |
LIG_SH3_1 | 362 | 368 | PF00018 | 0.446 |
LIG_SH3_3 | 145 | 151 | PF00018 | 0.469 |
LIG_SH3_3 | 242 | 248 | PF00018 | 0.728 |
LIG_SH3_3 | 26 | 32 | PF00018 | 0.678 |
LIG_SH3_3 | 325 | 331 | PF00018 | 0.459 |
LIG_SH3_3 | 362 | 368 | PF00018 | 0.573 |
LIG_SH3_3 | 371 | 377 | PF00018 | 0.431 |
LIG_SH3_3 | 420 | 426 | PF00018 | 0.328 |
LIG_SH3_3 | 66 | 72 | PF00018 | 0.486 |
LIG_SH3_3 | 79 | 85 | PF00018 | 0.476 |
LIG_SH3_5 | 101 | 105 | PF00018 | 0.369 |
LIG_SUMO_SIM_par_1 | 129 | 136 | PF11976 | 0.371 |
LIG_SUMO_SIM_par_1 | 152 | 158 | PF11976 | 0.440 |
LIG_TRAF2_1 | 376 | 379 | PF00917 | 0.514 |
LIG_TYR_ITIM | 82 | 87 | PF00017 | 0.543 |
LIG_UBA3_1 | 318 | 326 | PF00899 | 0.527 |
LIG_WRC_WIRS_1 | 1 | 6 | PF05994 | 0.694 |
MOD_CK1_1 | 111 | 117 | PF00069 | 0.358 |
MOD_CK1_1 | 165 | 171 | PF00069 | 0.512 |
MOD_CK1_1 | 201 | 207 | PF00069 | 0.745 |
MOD_CK1_1 | 236 | 242 | PF00069 | 0.654 |
MOD_CK1_1 | 373 | 379 | PF00069 | 0.480 |
MOD_CK2_1 | 297 | 303 | PF00069 | 0.712 |
MOD_CK2_1 | 373 | 379 | PF00069 | 0.429 |
MOD_Cter_Amidation | 142 | 145 | PF01082 | 0.401 |
MOD_GlcNHglycan | 18 | 21 | PF01048 | 0.702 |
MOD_GlcNHglycan | 196 | 199 | PF01048 | 0.678 |
MOD_GlcNHglycan | 203 | 206 | PF01048 | 0.677 |
MOD_GlcNHglycan | 214 | 217 | PF01048 | 0.665 |
MOD_GlcNHglycan | 225 | 228 | PF01048 | 0.622 |
MOD_GlcNHglycan | 230 | 233 | PF01048 | 0.583 |
MOD_GlcNHglycan | 238 | 241 | PF01048 | 0.754 |
MOD_GlcNHglycan | 268 | 271 | PF01048 | 0.665 |
MOD_GlcNHglycan | 275 | 278 | PF01048 | 0.672 |
MOD_GlcNHglycan | 307 | 310 | PF01048 | 0.701 |
MOD_GlcNHglycan | 389 | 393 | PF01048 | 0.362 |
MOD_GlcNHglycan | 422 | 426 | PF01048 | 0.470 |
MOD_GSK3_1 | 194 | 201 | PF00069 | 0.701 |
MOD_GSK3_1 | 219 | 226 | PF00069 | 0.644 |
MOD_GSK3_1 | 228 | 235 | PF00069 | 0.620 |
MOD_GSK3_1 | 251 | 258 | PF00069 | 0.644 |
MOD_GSK3_1 | 285 | 292 | PF00069 | 0.686 |
MOD_NEK2_1 | 133 | 138 | PF00069 | 0.328 |
MOD_NEK2_1 | 162 | 167 | PF00069 | 0.393 |
MOD_PIKK_1 | 426 | 432 | PF00454 | 0.440 |
MOD_PK_1 | 257 | 263 | PF00069 | 0.577 |
MOD_PK_1 | 55 | 61 | PF00069 | 0.456 |
MOD_PKA_2 | 279 | 285 | PF00069 | 0.573 |
MOD_Plk_2-3 | 403 | 409 | PF00069 | 0.341 |
MOD_Plk_4 | 155 | 161 | PF00069 | 0.440 |
MOD_Plk_4 | 285 | 291 | PF00069 | 0.776 |
MOD_Plk_4 | 55 | 61 | PF00069 | 0.509 |
MOD_ProDKin_1 | 297 | 303 | PF00069 | 0.671 |
MOD_ProDKin_1 | 370 | 376 | PF00069 | 0.532 |
MOD_SUMO_rev_2 | 184 | 192 | PF00179 | 0.645 |
TRG_DiLeu_BaEn_2 | 123 | 129 | PF01217 | 0.371 |
TRG_ENDOCYTIC_2 | 313 | 316 | PF00928 | 0.481 |
TRG_ENDOCYTIC_2 | 387 | 390 | PF00928 | 0.440 |
TRG_ENDOCYTIC_2 | 84 | 87 | PF00928 | 0.530 |
TRG_ENDOCYTIC_2 | 94 | 97 | PF00928 | 0.401 |
TRG_ER_diArg_1 | 362 | 364 | PF00400 | 0.544 |
TRG_ER_diArg_1 | 418 | 420 | PF00400 | 0.449 |
TRG_NLS_MonoCore_2 | 392 | 397 | PF00514 | 0.469 |
TRG_NLS_MonoExtC_3 | 392 | 398 | PF00514 | 0.440 |
TRG_Pf-PMV_PEXEL_1 | 180 | 184 | PF00026 | 0.666 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HSF6 | Leptomonas seymouri | 63% | 100% |
A0A0S4J8C1 | Bodo saltans | 34% | 100% |
A0A3Q8IE70 | Leishmania donovani | 93% | 100% |
A0A3R7K0E7 | Trypanosoma rangeli | 42% | 100% |
A4HC99 | Leishmania braziliensis | 78% | 100% |
C9ZRL7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 43% | 100% |
E9AVN6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 90% | 100% |
V5BR42 | Trypanosoma cruzi | 43% | 100% |